Kolexia
Martin Laurent Oncologie radiothérapie
Martin Laurent
Oncologie radiothérapie
Hôpital Flaubert
Le Havre, France
52 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome épidermoïde Carcinomes Tumeurs de la tête et du cou Carcinome épidermoïde de la tête et du cou Glioblastome Tumeurs épidermoïdes Tumeurs de l'hypopharynx Tumeurs des sinus de la face Radiodermite

Collaborateurs

Voir plus
Kadra Gais
Kadra Gais
Chi Du Pays Des Hautes Falaises Fecamp, Fécamp, France
Sire Christian
Sire Christian
Hôpital du Scorff, Lorient, France
Albouy Baptiste
Albouy Baptiste
Clinique Les Ormeaux, Le Havre, France
Coutte Alexandre
Coutte Alexandre
Centre Hospitalier D'Amiens Salouël Site Sud, Salouël, France

Industries

Voir plus
MSD
4 collaboration(s)
Dernière en 2023
Ipsen
3 collaboration(s)
Dernière en 2022
Ferring
3 collaboration(s)
Dernière en 2022
Bayer
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Head and neck cancer patients under radiotherapy undergoing skin application of hydrogel dressing or hyaluronic acid: results from a prospective, randomized study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer   06 décembre 2023
P-105 COLSTAR study: Safety data on the first cohort of patients from the safety lead-in part of the study
Abstract Book of the ESMO 25th World Congress on Gastrointestinal Cancer 2023, Barcelona, Spain, 28 June - 1 July 2023   01 juin 2023
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology   28 octobre 2022
LBA33 5-year overall survival (OS) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) treated with xevinapant + chemoradiotherapy (CRT) vs placebo + CRT in a randomized, phase II study
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
LBA35 Avelumab-cetuximab-radiotherapy versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Randomized phase III GORTEC-REACH trial
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
La stéréotaxie, un traitement de radiothérapie innovant, enfin ...
Paris-Normandie   11 juin 2021
Validation interne au GORTEC du consensus international de délinéation des CTV-P pour les cancers des VADS (méthode de consensus formalisé) : résultats des phases de cotation
31e Congrès national de la Société française de radiothérapie oncologique   01 octobre 2020
LBA39 3-years follow-up of double-blind randomized phase II comparing concurrent high-dose cisplatin chemo-radiation plus xevinapant or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck
Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020   01 septembre 2020
LBA38 Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 “PembroRad” randomized trial
Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020   01 septembre 2020
TPExtreme randomized trial: Quality of Life (QoL) and survival according to second-line treatments in patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).
2020 ASCO Annual Meeting I   25 mai 2020